Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227448 · ClinicalTrials.gov registry record · Phase 2
Induced Hypertension for Acute Ischemic Stroke
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00227448: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT00227448 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00227448, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The ultimate goal of this multicenter, phase II study is to increase blood pressure until either a neurologic response is seen or a target mean arterial pressure of 30% above baseline is achieved. IV fluids, IV phenylephrine and/or IV norepinephrine are used to rapidly raise mean arterial pressure in a controlled manner as serial assessments of neurologic function are performed.
Interventions
- DRUG intravenous saline
- DRUG intravenous phenylephrine
- DRUG intravenous levophed
- DRUG oral midodrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00227448
The ClinicalTrials.gov registry entry for NCT00227448 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which intravenous saline is the first listed.
NCT00227448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00227448 about?
NCT00227448 is a clinical study titled "Induced Hypertension for Acute Ischemic Stroke". The ultimate goal of this multicenter, phase II study is to increase blood pressure until either a neurologic response is seen or a target mean arterial pressure of 30% above baseline is achieved. IV fluids, IV phenylephrine and/or IV norepinephrine are used to rapidly raise mean arterial pressure i...
What is the current status of trial NCT00227448?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2003-06. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00227448?
The interventions under investigation include: intravenous saline (DRUG), intravenous phenylephrine (DRUG), intravenous levophed (DRUG), oral midodrine (DRUG).
Who is sponsoring clinical trial NCT00227448?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.